Financhill
Buy
66

ARQT Quote, Financials, Valuation and Earnings

Last price:
$15.48
Seasonality move :
71.61%
Day range:
$14.18 - $15.79
52-week range:
$2.60 - $15.79
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
12.31x
P/B ratio:
11.20x
Volume:
5.2M
Avg. volume:
2.2M
1-year change:
478.76%
Market cap:
$1.8B
Revenue:
$59.6M
EPS (TTM):
-$1.79

Earnings Data

Next earnings date for ARQT
Feb 27
2025
Most recent earnings per share
-$0.33
Beat by $0.10
(Nov 6/2024)
Consensus Estimate
-$0.43
(Nov 6/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ARQT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/27/2025 Q4 $54.7M -- -- -$0.30 --
11/06/2024 Q3 $37.3M $44.8M -$0.33 -$0.43 $0.10
08/14/2024 Q2 $29.1M $30.9M -$0.42 -$0.53 $0.11
05/14/2024 Q1 $15.1M $49.6M -$0.32 -$0.73 $0.41
02/27/2024 Q4 $11.4M $13.5M -$0.72 -$0.80 $0.08
11/03/2023 Q3 -- -- -$0.73 -$0.91 $0.18
08/08/2023 Q2 -- -- -$1.16 -$1.25 $0.09
05/09/2023 Q1 -- -- -$1.31 -$1.26 -$0.05
02/28/2023 Q4 -- -- -$1.18 -$1.44 $0.26
11/08/2022 Q3 -- -- -$1.89 -$1.75 -$0.14
08/04/2022 Q2 -- -- -$1.31 -$1.42 $0.11
05/05/2022 Q1 -- -- -$1.27 -- --
02/22/2022 Q4 -- -- -$1.42 -- --
11/04/2021 Q3 -- -- -$1.14 -- --
08/05/2021 Q2 -- -- -$0.84 -- --
05/06/2021 Q1 -- -- -$0.76 -- --
02/16/2021 Q4 -- -- -$0.79 -- --
11/05/2020 Q3 -- -- -$1.01 -- --
08/11/2020 Q2 -- -- -$0.94 -- --
05/12/2020 Q1 -- -- -$1.15 -- --
12/31/2019 Q4 -- -- -$0.36 -- --
09/30/2019 Q3 -- -- -$0.80 -- --
06/30/2019 Q2 -- -- -$0.46 -- --
03/31/2019 Q1 -- -- -$0.37 -- --
12/31/2018 Q4 -- -- -$0.31 -- --

Arcutis Biotherapeutics Earnings Questions

  • How Much did Arcutis Biotherapeutics Generate in Revenue Last Quarter?

    Arcutis Biotherapeutics reported $44.8M worth of top line sales in its most recent quarter.

  • Did Arcutis Biotherapeutics Beat Earnings Last Quarter?

    Arcutis Biotherapeutics announced earnings per share of -$0.33 which represents a beat of analyst forecast a -$0.43 per share.

  • Is Arcutis Biotherapeutics Profitable?

    Arcutis Biotherapeutics reported $39.3M that represents $0.32 per share over the last quarter.

  • What is the Analyst Consensus for Arcutis Biotherapeutics EPS Next Year?

    Arcutis Biotherapeutics's earnings are forecast to decrease from -$3.78 per share to -$3.94 per share next year representing a decrease of -63.67%.

  • When is Arcutis Biotherapeutics's Earnings Date?

    Arcutis Biotherapeutics's next earnings date is February 27, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is down 0.51% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 7.38% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 5.32% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock